CHELSEA NEWREN: Open Payments
NPI 1487298121 · BARRINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 17 payments from 10 companies in 2025. Trend: 2023 $862 · 2024 $830 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $99 |
| Novo Nordisk Inc | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $16 |
Products named: NURTEC ODT, REXULTI, Ozempic, TRELEGY ELLIPTA, JARDIANCE, Auvelity, CAPVAXIVE, GEMTESA.
Industry payments across IL — which companies pay providers there.
